PROVE fluctuated 42% in 24 hours: SP1v6 mandatory upgrade drives surge in network activity
Bitget Pulse2026/05/21 07:06Volatility Overview
PROVE price has surged from a low of $0.2210 to a high of $0.3138 in the past 24 hours, currently at $0.3129, with a fluctuation amplitude of 42.0%.
According to CoinGecko data, the 24-hour trading volume reached $34.52 million, up 103% from the previous day, indicating a significant increase in market activity.
Brief Analysis of the Reasons for the Abnormal Movement
- Core Driver: SP1 v6 Mandatory Upgrade
Succinct officially announced on May 19th the removal of Prover Network support for v5; all participants must upgrade to v6 to maintain service continuity. This upgrade directly stimulated a surge in prover activity and proof requests, becoming the main catalyst for the price movement in the past 24 hours.
- Secondary Factors: Recent Adoption and Liquidity Improvement
Base Network had previously integrated SP1 for ZK proofs, and the exposure to the Turkish market following the CoinTR listing on May 14th jointly supported short-term demand.
All of the above are publicly accessible official announcements and market data; there are no other major news or whale large transfer records.
Market Views and Outlook
The community and analysts generally attribute this surge to short-term network usage growth brought by the SP1 v6 upgrade, rather than a breakthrough in long-term fundamentals. Some opinions point out that future token unlocks for investors and contributors (with only 19.5% currently in circulation) may bring selling pressure, and it is necessary to monitor the actual growth in proof request volume after the upgrade.
In the short term, the price may remain highly volatile, and it is recommended to closely track official updates from Succinct and on-chain proof activity data.
Note: This analysis is automatically generated by AI based on public data and on-chain monitoring, and is for informational reference only.Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
The "Outlier" Investment Art in the New Era of Berky

Chevron (CVX.US) explores alternative hedging for Middle East supply disruptions: targets Argentina and the Mediterranean to drive global LNG growth, seeks deal with India
Chevron is focusing on Argentina and the Mediterranean region, seeking global growth in liquefied natural gas, and plans to reach an agreement with India.

Energy and food price pressures intensify, potentially triggering an inflation rebound! The Bank of England may struggle to remain "calm" as market rate hike bets surge
The upward pressure on energy prices caused by the unresolved Middle East war is mounting. New risks are also approaching, which may keep inflation above the Bank of England’s 2% target for most of next year.

AstraZeneca (AZN.US) Breast Cancer Drug Etcamah Faces Setback in Phase III Clinical Trial, Potentially Impacting Billions in Sales
Bloomberg Intelligence analyst John Murphy stated that the setback in AstraZeneca's breast cancer drug trial could reduce sales in 2035 by $2.6 billion to $3.8 billion.
